Peer Review History
| Original SubmissionMay 28, 2019 |
|---|
|
PONE-D-19-15052 Lactic Acid Containing Polymers Produced in Engineered Sinorhizobium meliloti and Pseudomonas putida PLOS ONE Dear %Dr% %Charles%, Thank you for submitting your manuscript to PLOS ONE. After the requirement of three reviewers for the evaluation, two of them present a strong criticism as it currently stands. Therefore, we invite you to carefully study all their considerations and submit a deeply revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Aug 31 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Francisco Martinez-Abarca, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript describes the production of lactic acid-containing polymers with medium-chain length units in Sinorhizobium meliloti and Pseudomonas putida. Many cases have been reported in various monomeric constituents using some bacterial platforms starting from 2008. In such a case, this is an example of the series study. Most recently Goto et al. reported the similar paper on the polymer with higher molar-fraction of lactic acid (> 4% in this paper) using Escherichia coli. Thy also provides the polymer properties. On the other hands, any new finding cannot be found in this paper. For example, in several points, new synthetic pathway, higher production titter, enriched lactic fraction, high molecular weight, new polymer properties. The reviewer has to consider this as a not-permitted assessment for publication in the present form. Reviewer #2: General Comments This manuscript describes the engineering of Sinorhizobium meliloti and Pseudomonas putida to synthesize novel co-polymers containing both polyhydroxyalkanoates (PHAs) and polylactic acid (PLAs). This work is novel and innovative. The manuscript is well written, the experimental approach and methods are appropriate and well described, and the conclusions are supported by the data. This manuscript will make an excellent contribution to the literature. There are only a few minor issues that need to be addressed before the manuscript may be published. Specific Comments Page 6, line 102: In the sentence, “…were provided by R. Nordeste, who constructed them as recently described (27)…”, please provide the institutional affiliation of R. Nordeste. Page 7, line 115: Please provide the vendor/manufacturer and its location for the culture medium “0.5*E2” Page 7, lines 120 to 121: In the sentence, “β-glucuronidase levels were determined as an indication of the transcript level of synthesized genes in both E. coli and S. meliloti strains.” Firstly, do the authors really mean E. coli here? Should this not be P. putida? Second, the assay described is protein (gene product) based. The authors cite two references, one which describes the use of the β-glucuronidase (GusA) assay in actinomycetes (reference 36) and the other describes the use of this assay as a measure of promoter activity in Lactic Acid bacteria (reference 37). In the current paper, the authors suggest that the assay is a direct indicator of the level of transcription of the genes of interest, but this is based on the assumption that the level of protein activity detected is proportional to the level of translation, and this in turn is proportional to the level of transcription. Is this actually the case? Can the authors provide some additional clarification about the relationship between transcription, translation, and enzyme activity in S. meliloti and P. putida? Figure 3: The resolution of the image for Figure 3 is very poor, and the bands in each lane have merge with each other so it is difficult to tell which lane is which. Can the authors replace this gel image with a better one? Page 11, lines 202 to 209: The authors refer to GusA, which is the gene product β-glucuronidase. For clarity, please revised the sentence on page 7, line 120, as follows: “β-glucuronidase (GusA) levels were determined…. Reviewer #3: The authors present a plasmid containing the genes encoding the propionate CoA transferase of C. propionicum and a modified PHA synthase I of Pseudomonas sp. MBEL 6-19. They introduced this into phaC mutants of S. melioti and P. putida and report the production of PLA homopolymer in S. meloti and of a novel quaterpolymer P(3HB-co-LA-co-3HH-co-3HO) in P. putida in the presence of octanoate. Though the production of a novel quaterpolymer is potentially interesting for applied processes, the manuscript, in its present state, has a number of shortcomings. p. 9, ll. 147-152: It would be helpful to have some more information on the genetic arrangement of the plasmid, e.g. how does the gusA reporter work, is it a transcriptional or translational fusion? How was the codon optimization achieved? What does the 532 or the 1400 stand for in the gene names? What RBSs are used and where were they located? p. 9, ll. 161-167 and Fig. 2: Why is there such a big difference in the fluorescence of SmUW257 comparing Fig. 2a to b? It should be comparable, as only IPTG is added in a) but this strain carries the empty plasmid. At the same time in 2b) it is hard to see a difference between the negative control (SmUW255) and the positive control (SmUW257). In my opinion this assay is not suitable to draw quantitative conclusions, only qualitative if any, as fluorescence depends on the amount and density of cells, which is hard to equal in solid phase medium. To get a rough estimation on the amount of polymer produced, the authors could repeat this plate experiment ensuring that the same amount of cells is plated or stain liquid cultures with the same OD (better cell count). p.10, ll. 174-179 and Fig. 3: In MHO nothing can be concluded form this WB. Apart from the fact, that it is hard to distinguish the different lanes, no band is observed in the positive control, and the rest is mainly smear. How did the authors ensure that the same amount of protein is loaded in each lane, this should be stated in the M&M part or a Coomassie stained gel should be shown. Which lanes show the sample without IPTG, which is mentioned in the manuscript? p. 10, Polymer production (Fig.4): How many independent replicates where analyzed? What do the error bars represent? Is the % polymer referred to CDW? p. 11, Tab. 2: Why is the PLA production negatively correlated to the lactic acid concentration in the medium? Is that expected? Please comment on this. Fig. 5 and 6: Information on how many replicates were analyzed and what the error bar represent is missing. It would be more coherent to have in Fig. 5b and 6b the same order of the samples (from day 1 to 3 or vice versa). p. 12, ll. 227-228: The authors state that the gusA reporter expression is inversely proportional to PHB production. I don’t see a correlation between the expression and the polymer content. The GusA activity, which serves a s a proxy for gene expression, seems to be either on or off. The authors should perform a correlation and include a correlation coefficient to support this statement p.12, l. 229: Reference is made to S1, however it is not available. p.12, l. 230: How was the significance determined? Fig. 7a is redundant with Fig. 7b. and can be omitted from the manuscript. p.14, l. 265: Did the authors mean sodium octanoate? Fig 9a: When were the samples taken? Is this result of only one analysis? Please comment on this. Fig. 9b: How do the authors explain the difference in CDW in PPU20, PPU21, and PPU19? PPU19 reaches more than twice the CDW of the wt strain in LB medium. Why is this not observed with minimal medium? Is that a common phenotype, or just observed in this specific experiment? Technical comments: 1. Information on media composition is completely missing (YM, TY, 0.5*E2) 2. A list of abbreviations would be helpful (especially for the polymer abbreviations, HB, LA, HH. HV etc.). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-15052R1 Lactic Acid Containing Polymers Produced in Engineered Sinorhizobium meliloti and Pseudomonas putida PLOS ONE Dear %Dr% %Charles%, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Feb 03 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Francisco Martinez-Abarca, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have adequately address the concerns of this reviewer, and is now acceptable for publication. Reviewer #3: The manuscript in its present state is more a short communication than a research article. In their revised version the authors have deleted all controversial data, and replaced part of figure 9 with table 3. In the first part the authors show that an already published pathway for polymer production works plasmid-based in S. meliloti, however there is no benefit over the wildtype strain neither in terms of polymer content nor in composition. Only when the PHB pathway is blocked, small amounts of PLA are detectable. Furthermore, there is the unexplained paradox of induction of transcription with IPTG and polymer accumulation. It might be due to metabolic burden, simultaneous degradation of the polymer, or a disbalance of the enzymatic machinery. The authors did not analyze this in more detail. Growth curves and rates could give a hint on this. In my opinion, this first part of the manuscript is marginally innovative and does not contribute significantly to the field. In the second part, the authors show that by implementing this pathway in P. putida a novel co-polymer can be produced up to around 40% of the CDW. This is new and interesting and a good starting point for further investigations. Some issues should be corrected before acceptance: 1) Material and methods need to be adapted to the shortens version of this article, e.g. no data is shown for P. putida grown in liquid LB medium for polymer production, however this is still part of this section. 2) The number of analyzed replicates should be stated, either in the figure or table legends or in the Material and methods section. 3) p. 11 l. 195/196: how can there be error bars in a table? Delete this sentence. 4) p.15 l. 238 and table 3: see above and numbers are not presented with +/- standard deviation. Why do the authors use a different nomenclature for the P. putida strains in this table? Or are these other strains? 5) p. 17 ll. 314-320: This sentence is hard to understand as it is very long. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Lactic Acid Containing Polymers Produced in Engineered Sinorhizobium meliloti and Pseudomonas putida PONE-D-19-15052R2 Dear Dr. Charles, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Francisco Martinez-Abarca, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-15052R2 Lactic Acid Containing Polymers Produced in Engineered Sinorhizobium meliloti and Pseudomonas putida Dear Dr. Charles: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Francisco Martinez-Abarca Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .